![]() |
|
|
Vol. 281, Issue 1, 34-40, 1997
Department of Internal Medicine, Veterans Affairs Medical Center and University of Michigan School of Medicine, Ann Arbor, Michigan
| |
Abstract |
|---|
|
|
|---|
Hepatic organic cation transport consists, in part, of carrier-mediated sinusoidal uptake stimulated by an inside-negative membrane potential and canalicular excretion driven by electroneutral organic cation/H+ exchange. Intracellular organic cation transport involves sequestration into acidified organelles, also mediated by organic cation/H+ exchange. A sinusoidal organic cation transporter has been cloned; however, canalicular organic cation transport has not been characterized at the molecular level. On the assumption that hepatic organic cation/H+ exchange resembles monoamine transport in synaptic vesicles, we examined, using canalicular rat liver plasma membrane vesicles, the transport of 1-methyl-4-phenylpyridinium (MPP+), a neurotoxin taken up by a synaptic vesicular monoamine transporter that has been cloned. Under voltage-clamped conditions, an outwardly directed H+ gradient stimulated [3H]MPP+ uptake, compared with uptake under pH-equilibrated conditions, consistent with electroneutral MPP+/H+ exchange. Substrates for canalicular organic cation/H+ exchange cis-inhibited pH-dependent MPP+ uptake. Equilibrium exchange of [14C]tetraethylammonium was inhibited by MPP+ in a concentration-dependent manner, consistent with a direct interaction of MPP+ with the organic cation carrier. Carrier-mediated MPP+ uptake exhibited saturability, with kinetic parameters similar to those described for canaliculartetraethylammonium+/H+ exchange. Canalicular [3H]MPP+ uptake was ATP-independent and, thus, distinct from P-glycoprotein-mediated efflux. The finding that MPP+ is a substrate for canalicular organic cation/H+ exchange is applicable to studies, using degenerate oligonucleotides complementary to sequences conserved in neurotransmitter transporters, aimed at cloning this transporter.
| |
Introduction |
|---|
|
|
|---|
The liver plays an essential role
in the uptake and elimination of a wide range of endobiotics and
xenobiotics, including secondary, tertiary or quaternary amines bearing
a net positive charge on one or more nitrogen groups at physiological
pH. Previous studies, using isolated perfused liver (Meijer et
al., 1970
) and isolated hepatocytes (Eaton and Klaassen, 1978
; Mol
et al., 1988
), established that the hepatobiliary transport
of organic cations is a carrier-mediated transport process, dependent
on physicochemical features such as lipophilicity and molecular weight.
Recent studies in isolated liver plasma membrane vesicles have begun to
characterize both the driving force for carrier-mediated hepatic
organic cation uptake and the mechanism for canalicular organic cation
excretion. At least three sinusoidal organic cation transport processes
have been identified. Sinusoidal uptake of the endogenous organic
cation N1-methylnicotinamide was found to be
mediated by an electroneutral organic cation/H+ antiport
(Moseley et al., 1990
). In addition, a
thiamine/H+ antiport is present on the sinusoidal membrane
that is, on the basis of substrate specificity studies, distinct from
N1-methylnicotinamide/H+ exchange
(Moseley et al., 1992b
). In contrast, transport of the exogenous organic cation TEA across the sinusoidal membrane was found
to be a carrier-mediated process stimulated by an inside-negative membrane potential, whereas canalicular transport was driven by an
organic cation/H+ antiport (Moseley et al.,
1992a
). Canalicular organic cation/H+ exchange may reflect,
in part, the exocytic insertion of this transporter from an acidified
intracellular compartment to this membrane domain. ATP-dependent
organic cation uptake has been demonstrated in both purified rat liver
multivesicular bodies, i.e., prelysosomal endocytic vesicles
that are acidified by an electrogenic H+-ATPase (Van Dyke
et al., 1992
), and lysosomes (Moseley and Van Dyke, 1995
).
Intracellular sequestration of organic cations into acidified
compartments in this manner may reduce the free cytoplasmic concentration of organic cations to values at or below their Nernst potentials and may account for the absence of an active transport process for certain organic cations at the sinusoidal membrane domain.
Using functional expression cloning in Xenopus oocytes, an
organic cation transporter (OCT1) has been identified (Grundemann et al., 1994
). This cDNA codes for a 62-kDa protein that is
not homologous to any other known protein and that has the functional characteristics of basolateral organic cation uptake in kidney and
liver (Grundemann et al., 1994
). Organic cation uptake
mediated by OCT1 is not affected by H+ gradients and
exhibits a Km >10 times lower than the apparent Km of renal brush-border organic
cation/H+ exchange (Grundemann et al., 1994
).
Therefore, organic cation/H+ exchange, localized to the
apical membrane where it can govern organic cationic drug excretion,
has not been characterized at the molecular level in any epithelium,
despite considerable effort, suggesting the need for alternative
strategies.
The process of intraneuronal sequestration of neurotransmitters is
mediated by the vesicular neurotransmitter transporters, among which
the VMATs have been the best studied (Schuldiner et al.,
1995
). The VMATs use a H+ electrochemical gradient
generated by a vacuolar-type H+-ATPase to couple efflux of
two H+ ions with neurotransmitter uptake into synaptic
vesicles. Several human, bovine and rat VMATs have been cloned
(Erickson et al., 1992
; Liu et al., 1992
). Shared
features of canalicular and lysosomal organic cation/H+
exchange (Moseley and Van Dyke, 1995
; Moseley et al., 1992a
) have led us to speculate that hepatic organic cation transport resembles monoamine transport in synaptic vesicles. Therefore, in this
study we have examined, using rat cLPM vesicles, the transport of
MPP+, a neurotoxin that causes parkinsonism-like symptoms
and that is taken up in exchange with H+ (Moriyama et
al., 1993
) by VMATs. By demonstrating that MPP+, a
substrate for VMATs, is also a substrate for canalicular organic cation/H+ exchange, we have taken the initial step in a
strategy that may lead to the cloning of the hepatic organic
cation/H+ exchanger.
| |
Methods |
|---|
|
|
|---|
Materials. N-[methyl-3H]MPP+ (80 Ci/mmol), [14C]TEA bromide (3.0 mCi/mmol) and [6-3H]taurocholic acid (2.1 Ci/mmol) were purchased from DuPont-New England Nuclear (Boston, MA). Mepiperphenidol [Darstine, (1,3-hydroxy-5-methyl-4-phenylhexyl)-1-methylpiperidinium bromide)] was a gift from Merck, Sharp & Dohme. TBuMA was purchased from Fluka Chemical (Ronkonkoma, NY). All other chemicals and reagents were purchased from Sigma Chemical Co. (St. Louis, MO). Valinomycin and carbonyl cyanide p-trifluoromethoxyphenylhydrazone were stored in absolute ethanol (Aaper Alcohol and Chemical, Shelbyville, KY). When used, ethanol was also added to controls; the total concentrations of ethanol in membrane vesicle suspensions were identical and did not exceed 0.25% (v/v). All water used in preparing media was deionized, and all solutions were filtered through 0.22-µm Millipore filters before use.
Preparation of rat liver plasma membrane vesicles.
The
method for isolation of blLPM and cLPM vesicles, as well as their
biochemical and morphological characterization, has been described in
detail elsewhere (Meier et al., 1984b
; Moseley et
al., 1986
). These studies have demonstrated minor contamination with intracellular organelles and nearly complete separation of cLPM
from blLPM vesicles, as reflected by the virtual absence of
Na+,K+-ATPase activity, glucagon-stimulatable
adenylate cyclase activity and intact secretory components in cLPM
vesicles (Meier et al., 1984b
). Freeze-fracture analysis has
revealed that ~80% of cLPM and ~73% of blLPM vesicles exhibit
right-side-out configuration (Meier et al., 1984a
; Moseley
et al., 1986
), in which the extravesicular membrane face
corresponds to the bile luminal or sinusoidal surface, respectively,
in vivo. Immediately after isolation, membranes were
suspended in the desired incubation medium (exact composition is
designated in the figure and table legends), at a protein concentration of 5 to 10 mg/ml, and stored at
70°C before transport studies. Protein concentration was measured by the method of Lowry et
al. (1951)
, using bovine serum albumin as standard. Interference
of various buffer solutions with the protein assay was accounted for by
determining separate standard curves for each buffer system.
Lysosome preparation.
Lysosomes were purified from fasting
male rat livers as previously described (Moseley and Van Dyke, 1995
;
Van Dyke, 1993
; Yamada et al., 1984
), 18 hr after i.v.
injection of 60 mg of fluorescein isothiocyanate-dextran dissolved in
0.9% saline. Lysosomes obtained in this manner appear to be free of
contamination by other organelles when assessed by electron-microscopic
morphological or marker enzyme analysis (Van Dyke, 1993
; Yamada
et al., 1984
). Lysosomes were resuspended in ice-cold buffer
containing 140 mM potassium gluconate, 70 mM sucrose and 30 mM
Bis-Tris, pH 7.0. Lysosomes were kept at 4°C for 1 to 2 hr before
use, to allow equilibration of proton gradients, and were used fresh
within 4 hr of preparation. Protein concentrations were measured by the
method of Lowry et al. (1951)
.
Transport measurements. Frozen membrane vesicle suspensions were rapidly thawed by immersion in a 37°C water bath, diluted to the desired protein concentration (3-5 mg/ml) and vesiculated by aspiration 10 times through a 25-gauge needle. Transmembrane transport of [3H]MPP+ (0.25 µCi/sample), [14C]TEA (0.1 µCi/sample) and [3H]taurocholate (0.25 µCi/sample) was measured by a rapid Millipore filtration technique. Uptake into 20 µl of membrane vesicle suspension was initiated at 25°C by addition of 80 µl of reaction medium containing radiolabeled substrate. The exact composition of the reaction media is given in the figure and table legends for the individual experiments. After incubation for the designated time intervals, transport was terminated by the addition of 3 ml of ice-cold stop solution, consisting of 204 mM sucrose, 150 mM potassium gluconate, 10 mM HEPES/Tris, pH 7.5, 5 mM magnesium gluconate, 0.2 mM calcium gluconate and 1 mM TBuMA (for uptake studies involving pH gradients); 175 mM sucrose, 150 mM potassium gluconate, 10 mM HEPES/Tris, pH 7.5, 5 mM magnesium gluconate, 0.2 mM calcium gluconate and 1 mM TBuMA (for electrogenicity studies); or 250 mM sucrose, 10 mM HEPES/Tris, pH 7.4, 0.2 mM CaCl2, 10 MgCl2 and 1 mM TBuMA (for ATP-dependency studies). For studies of the lysosomal uptake of [3H]MPP+, uptake buffer contained 140 mM potassium gluconate, 70 mM sucrose, 30 mM Tris, pH 7.0, and an ATP-regenerating system (9 mM phosphoenolpyruvate, 2.5 mM NADH, 16 U/ml pyruvate kinase and 19 U/ml lactate dehydrogenase), and uptake was initiated by addition of lysosomes to buffer containing [3H]MPP+ and either 5 mM magnesium gluconate or 5 mM MgATP. Aliquots of the incubation mixture were removed at designated times, and uptake was terminated by the addition of 3 ml of ice-cold stop solution, consisting of 140 mM potassium gluconate, 70 mM sucrose and 30 mM Tris, pH 7.0. Membrane vesicle- and lysosome-associated ligands were separated from free ligand by filtration under vacuum through a 0.45-µm Millipore filter (type HAWP; Millipore Corp., Bedford, MA) that had been presoaked in stop solution. The filter was washed twice with 3 ml of stop solution, dissolved in Redisolv HP (Beckman Instruments, Palo Alto, CA) and counted in a Beckman LS 1801 liquid scintillation counter. Nonspecific binding of isotope to filter and membrane vesicles (determined in each experiment by addition, at 0-4°C, of incubation medium and stop solution to 20 µl of membrane suspension) was subtracted from all vesicle uptake determinations. Nonspecific binding of isotope to filter and lysosomes (determined in duplicate at time 0) was subtracted from all lysosome uptake determinations. Unless otherwise indicated, all incubations were performed in triplicate, and all observations were confirmed with three or more separate preparations.
Data analysis. All values are expressed as mean ± S.E. The data were compared by Student's t test; differences were considered to be statistically significant at P < .05.
| |
Results |
|---|
|
|
|---|
The effect of an outwardly directed H+ gradient on
[3H]MPP+ uptake was examined first in cLPM
vesicles (fig. 1). Uptake of 1 µM MPP+ in
the presence of an outwardly directed H+ gradient
(pHin 5.9/pHout 7.9), under voltage-clamped
conditions (K+in = K+out in the presence of the K+
ionophore valinomycin at 5 µg/mg protein), was significantly greater
than uptake under pH-equilibrated (pHin
7.9/pHout 7.9) conditions. Intravesicular volume, as
reflected by equilibrium uptake values, was similar in the presence and
absence of a pH gradient. As an additional control to exclude an effect
of pH per se on MPP+ uptake, uptake of 1 µM
MPP+ was measured, in separate experiments, under
pHin 5.9/pHout 5.9 conditions. As also shown in
figure 1, MPP+ uptake in the presence of an outwardly
directed H+ gradient (pHin
5.9/pHout 7.9) was significantly greater than uptake under
these pH-equilibrated conditions.
|
As additional evidence for the presence of carrier-mediated MPP+ transport in cLPM vesicles, we next examined whether the presence of unlabeled intravesicular organic cationic substrate was capable of stimulating the uptake of extravesicular [3H]MPP+ (trans-stimulation). As shown in table 1, in the absence of a pH gradient, the initial rates of 1 mM [3H]MPP+ uptake were significantly greater in cLPM vesicles preloaded with 5 mM TEA. Equilibrium uptake values (60 min) were similar in the presence or absence of intravesicular TEA.
|
For cis-inhibition studies, the effects of several organic
cations on pH-dependent MPP+ uptake in cLPM vesicles were
examined (table 2). Substrates for canalicular organic
cation/H+ exchange, including TEA (Moseley et
al., 1992a
), TBuMA (Moseley et al., 1996
), darstine,
primaquin and decynium (Moseley and Van Dyke, 1995
), significantly
inhibited pH-dependent MPP+ uptake.
N-Methylnicotinamide, an endogenous organic cation that is
not a substrate for canalicular organic cation/H+ exchange,
had no effect on pH-dependent MPP+ uptake. These findings
are consistent with MPP+ being a substrate for canalicular
organic cation/H+ exchange. Because it is possible that
these organic cations exert cis-inhibitory effects on
pH-dependent MPP+ uptake by dissipating the H+
gradient, rather than by directly interacting with the organic cation
carrier, the effect of MPP+ on TEA uptake under equilibrium
exchange conditions was also examined. As shown in figure
2, TEA uptake measured under equilibrium conditions
([TEA]in = [TEA]out = 1 mM and
pHin = pHout = 7.4) was inhibited by
MPP+ in a concentration-dependent manner. Inhibition of TEA
uptake by MPP+ in the absence of a H+ gradient
is consistent with a direct interaction of MPP+ with the
canalicular organic cation/H+ exchanger.
|
|
Canalicular membrane vesicles exhibit ATP-dependent transport of
daunomycin and other cytotoxic drugs, mediated by P-glycoprotein (Kamimoto et al., 1989
). In other epithelia,
P-glycoprotein-mediated multidrug resistance is characterized by a
broad range of structurally heterogeneous substrates, including
hydrophobic organic cations of low molecular weight (Nogae et
al., 1989
; Pearce et al., 1989
). Recently,
ATP-dependent transport of certain bulky aromatic organic cations
across the canalicular membrane was described (Muller et
al., 1994
). However, canalicular transport of TEA and TBuMA was
found to be ATP-independent (Moseley and Van Dyke, 1995
; Moseley et al., 1996
). Therefore, in the absence of a pH gradient,
the effect of ATP on the time course of MPP+ uptake was
examined. As shown in table 3, there was no significant difference in MPP+ uptake in the presence of ATP and an
ATP-regenerating system vs. MPP+ uptake in the
absence of ATP. As a control, the effect of ATP on the time course of
[3H]taurocholate uptake was also examined. As previously
shown (Nishida et al., 1991
), taurocholate uptake was
significantly enhanced in the presence of ATP. These results suggest
that the canalicular transport of MPP+ is also
ATP-independent and distinct from P-glycoprotein-mediated drug efflux.
|
The kinetic features of pH-dependent MPP+ transport were
also determined. In cLPM vesicles, the concentration dependence of the
initial uptake rates was studied over a MPP+ concentration
range of 0.001 to 1 mM. Carrier-mediated uptake was determined by
subtracting a diffusional component of uptake ([3H]MPP+ uptake under pH-equilibrated
conditions) from total uptake. As shown in figure 3,
carrier-mediated uptake exhibited saturability with increasing
concentrations of MPP+. The data in figure 3 (inset) are
presented as an Eadie-Hofstee plot (initial velocity/substrate
concentration vs. initial velocity), demonstrating a single
transport system with an apparent Km of 0.3 mM
and an apparent Vmax of 0.4 nmol/mg protein/15
sec.
|
Hepatic lysosomes sequester certain organic cationic drugs, most likely
via an organic cation/H+ antiport driven by
H+-ATPase, with characteristics of canalicular organic
cation/H+ exchange (Moseley and Van Dyke, 1995
). These
observations led us to speculate that this intracellular compartment
may undergo exocytosis at the canalicular membrane domain, resulting in
the insertion of an organic cation/H+ exchanger that would
favor net organic cation excretion into bile. As shown in figure
4, the uptake of 10 µM
[3H]MPP+ by rat liver lysosomes was also
significantly increased by the presence of ATP in the incubation
buffer.
|
Sinusoidal uptake of TEA (Moseley et al., 1992a
) and TBuMA
(Moseley et al., 1996
) is stimulated by an inside-negative
membrane potential. The effect of membrane potential on
MPP+ transport in blLPM vesicles was, therefore, also
examined. As demonstrated in figure 5, MPP+
uptake in blLPM vesicles was significantly greater in the presence than
in the absence of a valinomycin-induced intravesicular negative K+ diffusion potential.
|
| |
Discussion |
|---|
|
|
|---|
The present study demonstrates that hepatic MPP+
transport resembles that previously described for carrier-mediated TEA
and TBuMA transport (Moseley et al., 1992a
,
1996). In cLPM vesicles, transport is mediated by coupled exchange of
MPP+ for H+, whereas MPP+ uptake in
blLPM vesicles is mediated by an electrically conductive pathway. The
substrate specificity and kinetic features of
MPP+/H+ exchange in cLPM vesicles are similar
to those described for canalicular organic cation/H+
exchange (Moseley and Van Dyke, 1995
; Moseley et al.,
1992a
, 1996). MPP+ inhibits TEA uptake in a
concentration-dependent manner in cLPM vesicles in the absence of a
H+ gradient, consistent with a direct interaction of
MPP+ with the canalicular organic cation/H+
exchanger. Furthermore, rat liver lysosomes sequester MPP+
in the presence of ATP, similar to processes described for TEA (Moseley
and Van Dyke, 1995
) and TBuMA (Van Dyke et al., 1992
), which
most likely involves an organic cation/H+ antiport with
characteristics of canalicular organic cation/H+ exchange.
Although the hepatic transport of MPP+ has not been
characterized to the same extent as that of other organic cations
(Moseley and Van Dyke, 1995
; Moseley et al., 1992a
, 1996
),
these results establish MPP+ as a substrate for hepatic
organic cation transport processes and, in particular, canalicular
organic cation/H+ exchange.
MPP+ and its analog
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine are also substrates for
the organic cation/H+ exchanger in renal brush-border
membrane vesicles (Lazaruk and Wright, 1990
; Sokol et al.,
1987
). The finding that MPP+ is a substrate for the hepatic
transporter serves to reinforce the similarities in organic cation
transport by these two epithelia. Studies in isolated renal
brush-border and basolateral membrane vesicles have demonstrated that
carrier-mediated organic cation transport across the basolateral
membrane is driven by an inside-negative potential difference, whereas
apical transport is mediated by electroneutral organic
cation/H+ exchange (Pritchard and Miller, 1993
; Ullrich,
1994
). Intracellular transport of organic cations in the kidney
involves sequestration into acidified compartments mediated by organic
cation/H+ exchange (Pritchard et al., 1994
), a
process that is recapitulated in the liver (Moseley and Van Dyke, 1995
;
Van Dyke et al., 1992
).
MPP+ accumulates within isolated rat hepatocytes, resulting
in cell death (Singh et al., 1988
). Intracellular calcium
release from mitochondria plays a role in MPP+-induced
hepatotoxicity (Kass et al., 1988
), and MPP+
uptake, driven by the membrane potential, has been reported in liver
mitochondria (Ramsay and Singer, 1986
). The mechanisms, however, for
the hepatic uptake of MPP+ have not been previously defined
in a membrane vesicle model. Using functional expression cloning in
Xenopus laevis oocytes, a rat renal organic cation
transporter (OCT1) was recently identified, with features, including
potential-dependent but pH-independent uptake of TEA, characteristic of
basolateral organic cation uptake in the proximal tubule (Grundemann
et al., 1994
). MPP+ effectively inhibited TEA
uptake in OCT1 cRNA-injected oocytes (Grundemann et al.,
1994
). Northern blot analysis and in situ hybridization
suggest that this transporter is also expressed in liver and intestine
(Grundemann et al., 1994
). If so, it is distinctly possible
that OCT1 mediates sinusoidal MPP+ uptake, as described in
this study. The recent description of the hepatic uptake of
MPP+ by cultured rat hepatocytes and human embryonic kidney
cells heterologously expressing OCT1 (Martel et al., 1996
)
is consistent with our findings in blLPM vesicles. However, in all
studies to date, pH-dependent organic cation transport has not been
functionally expressed in the Xenopus oocyte model
(Grundemann et al., 1994
; Hori et al., 1992
), and
alternative strategies may be required to clone organic
cation/H+ exchangers.
Synaptic transmission involves the regulated release of
neurotransmitters stored in subcellular organelles into the synaptic cleft, followed by reuptake of neurotransmitters back to the
presynaptic terminal or into glial elements. The process of
intraneuronal sequestration is mediated by the vesicular
neurotransmitter transporters, among which the VMATs have been the best
studied (Schuldiner et al., 1995
). Whereas neurotransmitter
reuptake, except in the case of acetylcholine, is a
Na+-dependent process, the VMATs use an H+
electrochemical gradient generated by a vacuolar-type
H+-ATPase to couple efflux of two H+ ions with
neurotransmitter uptake. Several human, bovine and rat VMATs have been
cloned. VMAT1, expressed only in adrenal medulla, confers resistance to
MPP+ when transfected into Chinese hamster ovary cells (Liu
et al., 1992
). A transporter similar to but distinct from
VMAT1 has been identified in brain (VMAT2) (Erickson et al.,
1992
; Liu et al., 1992
). The predicted sequences of the
VMATs show significant homology with a growing class of drug-resistant
proteins from prokaryotes and eukaryotes that, on the basis of a
dependence of an H+ electrochemical gradient for transport
activity, have been termed toxin-extruding antiporters, or TEXANs
(Schuldiner, 1994
). Thus far, only the VMATs have been identified as
mammalian members of the TEXAN family (Schuldiner, 1994
). However, it
is possible that the mammalian TEXANs play more of a role in the whole
organism, other than neurotransmitter transport. Our finding that VMATs and canalicular organic cation/H+ exchange share
MPP+ as a substrate establishes the validity of a strategy,
using degenerate oligonucleotides complementary to sequences conserved in these neurotransmitter transporters, aimed at cloning canalicular organic cation/H+ exchange.
In conclusion, the neurotoxin MPP+ is a substrate for hepatic organic cation transport processes and, in particular, canalicular organic cation/H+ exchange, as previously described for TEA and TBuMA. By taking advantage of our understanding of the molecular mechanisms of monoamine transport in synaptic vesicles, which shares features with canalicular organic cation/H+ exchange, these findings provide a strategy that may lead to the cloning of this transporter.
| |
Acknowledgments |
|---|
We thank Brenda Vibbart for her editorial assistance.
| |
Footnotes |
|---|
Accepted for publication December 9, 1996.
Received for publication July 24, 1996.
1
This work was supported, in part, by the Medical
Research Service of the Department of Veterans Affairs (R.H.M.,
R.W.V.D.) and by National Institute of Diabetes and Digestive and
Kidney Diseases Grants DK39167 (R.H.M.) and DK38333 (R.W.V.D.). Part of
this work was presented at the annual meeting of the American Gastroenterological Association in San Francisco, CA, May 1996, and
published in abstract form (Moseley and Zugger, 1996
).
Send reprint requests to: Richard H. Moseley, M.D., Gastroenterology Section (111D), Veterans Affairs Medical Center, 2215 Fuller Road, Ann Arbor, MI 48105.
| |
Abbreviations |
|---|
blLPM, basolateral liver plasma membrane; cLPM, canalicular liver plasma membrane; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; MPP+, 1-methyl-4-phenylpyridinium; TBuMA, tributylmethylammonium; TEA, tetraethylammonium; VMAT, vesicular monoamine transporter.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. J. Dresser, A. T. Gray, and K. M. Giacomini Kinetic and Selectivity Differences between Rodent, Rabbit, and Human Organic Cation Transporters (OCT1) J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1146 - 1152. [Abstract] [Full Text] |
||||
![]() |
K. Niinuma, Y. Kato, H. Suzuki, C. A. Tyson, V. Weizer, J. E. Dabbs, R. Froehlich, C. E. Green, and Y. Sugiyama Primary active transport of organic anions on bile canalicular membrane in humans Am J Physiol Gastrointest Liver Physiol, May 1, 1999; 276(5): G1153 - G1164. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||